查看购物车
  • Traditional Chinese
  • English
北美近视治疗市场预测至 2030 年 - 区域分析 - 按类型、治疗、年龄层和最终用户
市场调查报告书
商品编码
1562242

北美近视治疗市场预测至 2030 年 - 区域分析 - 按类型、治疗、年龄层和最终用户

North America Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User
出版日期: | 出版商: The Insight Partners | 英文 109 Pages | 订单完成后即时交付

价格

2022年北美近视治疗市值为39.389亿美元，预计到2030年将达到73.3526亿美元；预计2022年至2030年复合年增长率为8.1%。

近视盛行率上升推动北美近视治疗市场

全球近视盛行率不断上升，是一个重大的公共卫生问题，尤其是儿童和年轻人的近视发病率不断上升。最近的一项研究估计，到 2050 年，世界上近 50% 的人口（即 50 亿人）将患有近视，高于目前 30% 的平均水平。在美国，近视发生率也在增加；据报道，这一比例为 42%，在短短 30 年内几乎翻了一番。多种因素促成了这一趋势，包括生活方式的改变、城市化进程的加快以及大量的近距离工作活动，例如长时间使用数位设备和有限的户外活动。虽然遗传倾向发挥一定作用，但环境因素也会导致近视率大幅上升。这些生活方式和环境因素的影响使人们更加了解遗传易感性和环境影响之间复杂的相互作用，进一步强调需要采取全面的策略来解决这个新兴的公共卫生问题。随着近视盛行率持续上升，人们越来越重视制定积极的干预措施、公共卫生运动和创新治疗方法，以减轻高度近视及其相关眼部併发症的长期影响，从而强调解决这一问题的重要性多方面的全球健康挑战。

北美近视治疗市场概况

北美近视治疗市场已细分为美国、加拿大和墨西哥。美国占据北美近视治疗市场的最大份额。美国市场的成长将归因于诸如近视相关视力丧失发生率的增加以及未经治疗的近视导致远视力损害的发生率上升等因素。此外，政府对眼睛健康和技术进步的支持不断增加是推动北美市场成长的重要因素。

美国近视治疗市场预计在未来几年将显着成长。近年来，近视盛行率不断增加，这推动了对有效治疗的需求。根据近视研究所 2023 年发布的资料，美国的盛行率为 42%，在短短三十年中几乎翻了一番。例如，布莱恩霍尔顿视力研究所 (Brien Holden Vision Institute) 的 2024 年近视意识週选择了《近视管理回顾》(Review of Myopia Management) 作为其官方联合赞助商。此次合作将有助于扩大近视宣传週的影响范围，该活动定于2024 年5 月13 日至19 日在国内和国际举行。患其他眼部疾病的风险增加-白内障和青光眼。这导致有助于预防或减缓近视进展的有效治疗的需求更大。推动美国近视治疗市场成长的另一个因素是先进技术和治疗方法的可用性。现在有多种近视治疗方法，包括矫正镜片、角膜塑身术和药物治疗。这些治疗方法变得越来越复杂和有效，有助于推动近视治疗的需求。最后，儿童近视盛行率的不断上升也推动了美国近视治疗市场的成长。随着越来越多的儿童被诊断出患有近视，更需要有效的治疗方法来帮助预防或减缓其发展。这导致了对专门为儿童设计的新疗法的研究和开发的投资增加。总体而言，随着越来越多的人意识到这种情况以及对有效治疗的需求增加，美国近视治疗市场预计在未来几年将会成长。

北美近视治疗市场收入及 2030 年预测（百万美元）

北美近视治疗市场细分

北美近视治疗市场按类型、治疗、年龄层、最终用户和国家分类。

根据类型，北美近视治疗市场分为高度近视、退化性近视和进行性近视。 2022 年，高度近视细分市场占据北美近视治疗市场最大份额。

在治疗方面，北美近视治疗市场分为低剂量阿托品眼药水、隐形眼镜、角膜塑形镜和屈光手术。 2022年，低剂量阿托品眼药水细分市场占据北美近视治疗市场最大份额。

依年龄组别划分，北美近视治疗市场分为成人近视和儿童近视。 2022 年，成人近视细分市场将占据更大的北美近视治疗市场。

根据最终用户，北美近视治疗市场分为医院和诊所、专科诊所和屈光手术中心。 2022 年，医院和诊所细分市场占据北美近视治疗市场最大份额。

依国家划分，北美近视治疗市场分为美国、加拿大和墨西哥。 2022年，美国在北美近视治疗市场份额中占据主导地位。

Bausch Health Companies Inc、Alcon AG、CooperVision Inc、Johnson & Johnson Vision Care Inc、Topcon Healthcare Solutions Inc、Ziemer Ophthalmic Systems AG、Nidek Co Ltd、Eyes Vision SL、Haag-Streit AG 和 Carl Zeiss AG。是北美近视治疗市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美近视治疗市场格局

  • 概述
  • PEST分析
  • 按公司分類的市占率分析

第 5 章：北美近视治疗市场 - 主要市场动态

  • 北美近视治疗市场 - 主要市场动态
  • 市场驱动因素
    • 近视盛行率上升
    • 提高近视治疗意识
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 用于治疗目标近视的先进技术的可用性不断提高
  • 未来趋势
    • 人工智慧在近视治疗的应用
  • 驱动因素和限制的影响：

第 6 章：近视治疗市场 - 北美市场分析

第 7 章：北美近视治疗市场分析 - 按类型

  • 高度近视
  • 退化性近视
  • 进行性近视

第 8 章：北美近视治疗市场分析 - 按治疗分类

  • 小剂量阿托品眼药水
  • 屈光手术
  • 隐形眼镜
  • 骨科矫形术

第 9 章：北美近视治疗市场分析 - 按年龄组

  • 成人近视
  • 儿童近视

第 10 章：北美近视治疗市场分析 - 按最终用户

  • 医院和诊所
  • 专科诊所
  • 屈光手术中心

第 11 章：北美近视治疗市场 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 12 章：产业格局

  • 概述
  • 近视治疗市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Bausch Health Companies Inc
  • Alcon AG
  • CooperVision Inc
  • Johnson & Johnson Vision Care Inc
  • Topcon Healthcare Solutions Inc
  • Ziemer Ophthalmic Systems AG
  • Nidek Co Ltd
  • Eyes Vision SL
  • Haag-Streit AG
  • Carl Zeiss AG

第 14 章：附录

Product Code: BMIRE00030510

The North America myopia treatment market was valued at US$ 3,938.90 million in 2022 and is expected to reach US$ 7,335.26 million by 2030; it is estimated to register a CAGR of 8.1% from 2022 to 2030.

Rising Prevalence of Myopia Fuels North America Myopia Treatment Market

The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world's population-or 5 billion people-will be myopic, up from the current average of 30%. The frequency of myopia is also increasing in the US; it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.

North America Myopia Treatment Market Overview

The North America myopia treatment market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America myopia treatment market. The market growth in the US will be due to factors such as the growing myopia-related occurrences of vision loss and rising incidence of distant vision impairment from untreated myopia. Furthermore, the rising government support for eye health and technological advancements are prominent factors propelling the North America market growth.

The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in recent years, which is driving the demand for effective treatments. The US has reported a prevalence of 42%, nearly doubling in just three decades, according to data released by the Myopia Institute in 2023. Furthermore, increasing awareness about myopia is also driving market growth. For instance, the Brien Holden Vision Institute's 2024 Myopia Awareness Week has selected Review of Myopia Management as its official co-sponsor. The collaboration will assist in expanding the reach of Myopia Awareness Week, which is scheduled for domestically and internationally, May 13-19, 2024. More people are becoming aware of the risks associated with myopia, such as an increased risk of developing other eye conditions-cataracts and glaucoma. This has led to a greater demand for effective treatments that can help prevent or slow down the progression of myopia. Another factor driving the growth of the myopia treatment market in the US is the availability of advanced technologies and treatments. Various treatments for myopia are now available, including corrective lenses, orthokeratology, and pharmacological treatments. These treatments are becoming increasingly sophisticated and effective, helping drive demand for myopia treatment. Finally, the growing prevalence of myopia among children is also driving the growth of the myopia treatment market in the US. As more children are diagnosed with myopia, there is a greater need for effective treatments that can help prevent or slow down its progression. This has led to increased investment in research and development of new treatments specifically designed for children. Overall, the US myopia treatment market is expected to grow in the coming years as more people become aware of the condition and demand for effective treatments increases.

North America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Myopia Treatment Market Segmentation

The North America myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the North America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest North America myopia treatment market share in 2022.

In terms of treatment, the North America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest North America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the North America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger North America myopia treatment market share in 2022.

Based on end user, the North America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest North America myopia treatment market share in 2022.

Based on country, the North America myopia treatment market is categorized into the US, Canada, and Mexico. The US dominated the North America myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Topcon Healthcare Solutions Inc, Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Eyes Vision SL, Haag-Streit AG, and Carl Zeiss AG. are some of the leading companies operating in the North America myopia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Myopia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Market Share Analysis, By Companies

5. North America Myopia Treatment Market - Key Market Dynamics

  • 5.1 North America Myopia Treatment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Myopia
    • 5.2.2 Increased Awareness of Myopia Treatment
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Rising Availability of Advanced Technologies for Treating the Targeted Myopia
  • 5.5 Future Trends
    • 5.5.1 Application of Artificial Intelligence in Myopia Treatment
  • 5.6 Impact of Drivers and Restraints:

6. Myopia Treatment Market - North America Market Analysis

7. North America Myopia Treatment Market Analysis - by Type

  • 7.1 High Myopia
    • 7.1.1 Overview
    • 7.1.2 High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Degenerative Myopia
    • 7.2.1 Overview
    • 7.2.2 Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Progressive Myopia
    • 7.3.1 Overview
    • 7.3.2 Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Myopia Treatment Market Analysis - by Treatment

  • 8.1 Low-Dose Atropine Eye Drops
    • 8.1.1 Overview
    • 8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Refractive Surgery
    • 8.2.1 Overview
    • 8.2.2 Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.2.3 LASIK
    • 8.2.4 PRK
  • 8.3 Contact Lenses
    • 8.3.1 Overview
    • 8.3.2 Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ortho-K
    • 8.4.1 Overview
    • 8.4.2 Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Myopia Treatment Market Analysis - by Age Group

  • 9.1 Adult Myopia
    • 9.1.1 Overview
    • 9.1.2 Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Childhood Myopia
    • 9.2.1 Overview
    • 9.2.2 Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Myopia Treatment Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Refractive Surgery Centers
    • 10.3.1 Overview
    • 10.3.2 Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Myopia Treatment Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Myopia Treatment Market
    • 11.1.2 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.1 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.2 US
      • 11.1.2.3 US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.3.1 US: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.3.2 US: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.3.3 US: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.3.4 US: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.3.5 US: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.4 Canada
      • 11.1.2.5 Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.5.1 Canada: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.5.2 Canada: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.5.3 Canada: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.5.4 Canada: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.5.5 Canada: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.6 Mexico
      • 11.1.2.7 Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.7.1 Mexico: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.7.2 Mexico: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.7.3 Mexico: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.7.4 Mexico: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.7.5 Mexico: Myopia Treatment Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Myopia Treatment Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bausch Health Companies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Alcon AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 CooperVision Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson & Johnson Vision Care Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Topcon Healthcare Solutions Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Ziemer Ophthalmic Systems AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Nidek Co Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eyes Vision SL
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Haag-Streit AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Carl Zeiss AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Myopia Treatment Market Segmentation
  • Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
  • Table 3. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 4. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 5. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 6. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 7. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 8. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 9. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 10. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 11. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 12. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 13. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 14. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 15. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 16. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 17. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 18. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 19. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 20. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 21. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 22. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 23. Recent Organic Growth Strategies in Myopia Treatment Market
  • Table 24. Recent Inorganic Growth Strategies in the Myopia Treatment Market
  • Table 25. Glossary of Terms, Myopia Treatment Market

List Of Figures

  • Figure 1. North America Myopia Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Myopia Treatment Market Revenue (US$ Million), 2022-2030
  • Figure 5. North America Myopia Treatment Market Share (%) - by Type (2022 and 2030)
  • Figure 6. High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
  • Figure 10. Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. LASIK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. PRK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
  • Figure 17. Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Myopia Treatment Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in Myopia Treatment Market